Is Parabilis Medicines, Inc. overvalued?

Parabilis Medicines, Inc. (PBLS) — key valuation metrics and fundamentals.

No verdict

Price

$28.43

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$3.47B

Dividend yield

0.0%

Return on equity

-23.1%

Sector

Healthcare

Fair value compares PBLS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks